Small Study Tests Colchicine for Moderate-to-Severe COVID-19
Authors call for larger clinical trials to further evaluate the efficacy and safety of colchicine as an adjunctive therapy for COVID-19
AAO-HNS Issues Guidance for Bell’s Palsy Treatment During COVID-19
Corticosteroid therapy and/or antiherpes viral therapy recommended for patients developing Bell's palsy after vaccination
Physician’s Briefing Weekly Coronavirus Roundup
Cannabis Dispensaries Negatively Linked to Opioid-Related Death
Particularly strong negative association seen for dispensary count with deaths caused by synthetic opioids other than methadone
First Federal COVID-19 Vaccination Sites to Open in California
One center will be housed in the Oakland Coliseum, another on the campus of California State University, Los Angeles
Patient-Ordered Testing May Up CRC Screening Adherence
Patients self-ordering FIT tests for colorectal cancer screening through an electronic reminder more likely to complete a kit
High Efficacy Reported for Sputnik V COVID-19 Vaccine
Interim analysis of data from phase 3 trial shows 91.6 percent efficacy at 21 days after the first dose of the vaccine
High Refined Grain Intake Ups Risk for Mortality, Major CVD Events
Highest category of total intake linked to increased risk for total mortality, major cardiovascular disease events, their composite
Companies Developing Vaccines Against New Coronavirus Variants
GlaxoSmithKline and CureVac to create vaccines that use messenger RNA to combat the virus
COVID-19 Outcomes Worse for Persons Living With Diagnosed HIV
COVID-19 diagnosis rates are similar for those with, without HIV, but hospitalization and death rates are up with HIV
